Update on malaria

Naing, 2014, Is Plasmodium vivax malaria a severe malaria? A systematic review and meta-analysis, PLoS Neglect Trop Dis, 8, e3071, 10.1371/journal.pntd.0003071 WHO. World Health Organization: World malaria report 2019; 2019. Ashley, 2018, Malaria, Lancet, 391, 1608, 10.1016/S0140-6736(18)30324-6 White, 2014, Malaria, Lancet, 383, 723, 10.1016/S0140-6736(13)60024-0 Dondorp, 2005, Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2, PLoS Med, 2, e204, 10.1371/journal.pmed.0020204 Cunnington, 2013, Piecing together the puzzle of severe malaria, Sci Transl Med, 5, 10.1126/scitranslmed.3007432 Udomsangpetch, 1989, Plasmodium falciparum-infected erythrocytes form spontaneous erythrocyte rosettes, J Exp Med, 169, 1835, 10.1084/jem.169.5.1835 Pain, 2001, Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria, Proc Natl Acad Sci USA, 98, 1805, 10.1073/pnas.98.4.1805 Baruch, 1995, Cloning the Plasmodium falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes, Cell, 82, 77, 10.1016/0092-8674(95)90054-3 de Jong, 2016, Systematic review of the role of angiopoietin-1 and angiopoietin-2 in Plasmodium species infections: biomarkers or therapeutic targets?, Malar J, 15, 581, 10.1186/s12936-016-1624-8 Desakorn, 2005, Stage-dependent production and release of histidine-rich protein 2 by Plasmodium falciparum, Trans R Soc Trop Med Hyg, 99, 517, 10.1016/j.trstmh.2004.11.014 Rubach, 2012, Plasma Plasmodium falciparum histidine-rich protein-2 concentrations are associated with malaria severity and mortality in Tanzanian children, PLoS One, 7, e35985, 10.1371/journal.pone.0035985 Hendriksen, 2012, Diagnosing severe falciparum malaria in parasitaemic African children: a prospective evaluation of plasma PfHRP2 measurement, PLoS Med, 9, e1001297, 10.1371/journal.pmed.1001297 Crompton, 2014, Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease, Annu Rev Immunol, 32, 157, 10.1146/annurev-immunol-032713-120220 Fowkes, 2016, Immunity to malaria in an era of declining malaria transmission, Parasitology, 143, 139, 10.1017/S0031182015001249 Malaguarnera, 2002, The immune response to Plasmodium falciparum malaria, Lancet Infect Dis, 2, 472, 10.1016/S1473-3099(02)00344-4 WHO. Severe malaria. Trop Med Int Health. 2014;19(Suppl. 1):7–131. Conroy, 2016, Acute kidney injury is common in pediatric severe malaria and is associated with increased mortality, Open Forum Infect Dis, 3, 10.1093/ofid/ofw046 von Seidlein, 2012, Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial, Clin Infect Dis, 54, 1080, 10.1093/cid/cis034 Bruneel, 2010, Severe imported falciparum malaria: a cohort study in 400 critically ill adults, PLoS One, 5, e13236, 10.1371/journal.pone.0013236 Dondorp, 2008, The relationship between age and the manifestations of and mortality associated with severe malaria, Clin Infect Dis, 47, 151, 10.1086/589287 John, 2010, Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria, Expert Rev Anti Infect Ther, 8, 997, 10.1586/eri.10.90 Zimmerman, 2010, Persistent cognitive impairment after cerebral malaria: models, mechanisms and adjunctive therapies, Expert Rev Anti Infect Ther, 8, 1209, 10.1586/eri.10.117 Shikani, 2012, Cerebral malaria: we have come a long way, Am J Pathol, 181, 1484, 10.1016/j.ajpath.2012.08.010 Bangirana, 2014, Severe malarial anemia is associated with long-term neurocognitive impairment, Clin Infect Dis, 59, 336, 10.1093/cid/ciu293 Boivin, 2002, Effects of early cerebral malaria on cognitive ability in Senegalese children, J Dev Behav Pediatr, 23, 353, 10.1097/00004703-200210000-00010 Fernando, 2010, The ‘hidden’ burden of malaria: cognitive impairment following infection, Malar J, 9, 366, 10.1186/1475-2875-9-366 Idro, 2005, Pathogenesis, clinical features, and neurological outcome of cerebral malaria, Lancet Neurol, 4, 827, 10.1016/S1474-4422(05)70247-7 Murphy, 2001, Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy, Am J Trop Med Hyg, 64, 57, 10.4269/ajtmh.2001.64.57 Krishna, 1994, Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance, Trans R Soc Trop Med Hyg, 88, 67, 10.1016/0035-9203(94)90504-5 Seydel, 2015, Brain swelling and death in children with cerebral malaria, N Engl J Med, 372, 1126, 10.1056/NEJMoa1400116 Taylor, 2012, Respiratory manifestations of malaria, Chest, 142, 492, 10.1378/chest.11-2655 White, 2018, Anaemia and malaria, Malar J, 17, 371, 10.1186/s12936-018-2509-9 Moraleda, 2017, Anaemia in hospitalised preschool children from a rural area in Mozambique: a case control study in search for aetiological agents, BMC Pediatrics, 17, 63, 10.1186/s12887-017-0816-x WHO. Guidelines for the Treatment of Malaria. 3rd edition. 2015;7. Su, 2015, The discovery of artemisinin and the Nobel Prize in Physiology or Medicine, Sci China Life Sci, 58, 1175, 10.1007/s11427-015-4948-7 Chu, 2016, Management of relapsing Plasmodium vivax malaria, Expert Rev Anti Infect Ther, 14, 885, 10.1080/14787210.2016.1220304 Llanos-Cuentas, 2019, Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria, N Engl J Med, 380, 229, 10.1056/NEJMoa1802537 Lacerda, 2019, Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria, N Engl J Med, 380, 215, 10.1056/NEJMoa1710775 WHO. Guidelines for the treatment of malaria. Third edition. Geneva 2015. Dellicour, 2017, First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: a meta-analysis of observational studies, PLoS Med, 14, e1002290, 10.1371/journal.pmed.1002290 Nayyar, 2012, Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa, Lancet Infect Dis, 12, 488, 10.1016/S1473-3099(12)70064-6 Chaccour, 2015, Falsified antimalarials: a minireview, Expert Rev Anti Infect Ther, 13, 505 Menard, 2017, Antimalarial drug resistance: a threat to malaria elimination, Cold Spring Harbor Perspect Med, 7 World Health O. Artemisinin resistance and artemisinin-based combination therapy efficacy: status report. Geneva: World Health Organization; 2018. Contract No.: WHO/CDS/GMP/2018.18. Ariey, 2014, A molecular marker of artemisinin-resistant Plasmodium falciparum malaria, Nature, 505, 50, 10.1038/nature12876 Collins, 2002, Extended clearance time after treatment of infections with Plasmodium malariae may not be indicative of resistance to chloroquine, Am J Trop Med Hyg, 67, 406, 10.4269/ajtmh.2002.67.406 Dondorp, 2010, Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial, Lancet, 376, 1647, 10.1016/S0140-6736(10)61924-1 Dondorp, 2005, Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial, Lancet, 366, 717, 10.1016/S0140-6736(05)67176-0 Kremsner, 2016, Intramuscular artesunate for severe malaria in african children: a multicenter randomized controlled trial, PLoS Med, 13, e1001938, 10.1371/journal.pmed.1001938 Esu, 2019, Artemether for severe malaria, Cochrane Database Syst Rev, 6 WHO. Rectal artesunate for pre-referral treatment of severe malaria. Geneva: World Health Organization; 2017. Varo, 2018, Adjunctive therapy for severe malaria: a review and critical appraisal, Malar J, 17, 47, 10.1186/s12936-018-2195-7 Maitland, 2019, Immediate transfusion in african children with uncomplicated severe anemia, N Engl J Med, 381, 407, 10.1056/NEJMoa1900105 Bhatt, 2015, The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015, Nature, 526, 207, 10.1038/nature15535 Ranson, 2016, Insecticide resistance in African anopheles mosquitoes: a worsening situation that needs urgent action to maintain malaria control, Trends Parasitol, 32, 187, 10.1016/j.pt.2015.11.010 Killeen, 2014, Characterizing, controlling and eliminating residual malaria transmission, Malar J, 13, 330, 10.1186/1475-2875-13-330 Chaccour, 2013, Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination, Malar J, 12, 153, 10.1186/1475-2875-12-153 Killeen, 2017, Developing an expanded vector control toolbox for malaria elimination, BMJ Global Health, 2, e000211, 10.1136/bmjgh-2016-000211 Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS Med. 2014;11:e1001685. Seder, 2013, Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine, Science (New York, NY), 341, 1359, 10.1126/science.1241800